Arcturus Therapeutics (ARCT) PT Lowered to $20 at Wells Fargo
Tweet
Share
E-mailGet Alerts ARCT Hot Sheet
Price: $8.23 +4.71%
Rating Summary:
13 Buy, 5 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 5 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo analyst Yanan Zhu lowered the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $20.00 (from $42.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
- Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
